Don’t Forget About the Liver! NASH in Patients With HIV

Download All
Learn about the prevalence, assessment, and current and future treatment landscape for nonalcoholic steatohepatitis in patients with HIV.
Jürgen K. Rockstroh, MD
Giada Sebastiani, MD
Mark S. Sulkowski, MD


The presence of obesity, metabolic syndrome, persistent elevation of ALT, or exposure to dideoxynucleoside analogues can trigger an evaluation for NAFLD and NASH, particularly in our aging population of patients with HIV.

Giada Sebastiani, MD Released: September 29, 2021

Here are my best practices to appropriately screen for and identify NASH among people with HIV.

Jürgen K. Rockstroh, MD Released: January 7, 2022

Here’s my take on why abnormal ALT is never “normal” and why patients with HIV and abnormal liver enzymes need our attention.

Mark S. Sulkowski, MD Released: January 10, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Theratechnologies Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings